Generics 7

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Rivastigmine tartrate manufacturers

7 products found

Filters

7 products found

rivastigmine tartrate

Capsules 1.5 mg, 3 mg, 4.5 mg, 6 mg

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA
Manufacturer #15910
This multinational pharmaceutical company focuses on a wide range of products, including prescription medications, over-the-counter drugs, APIs, and formulations. They have a strong presence in key global regions like North America, Europe, Japan, and Africa. Their expertise spans multiple therapeutic areas, particularly gastroenterology, cardiology, gynecology, diabetology, and oncology. They are known for their state-of-the-art manufacturing facilities that adhere to international standards such as USFDA, EU, MHRA UK, WHO Geneva, and TGA Australia. The company boasts a dedicated R&D team of over 350 scientists working on innovations in areas with unmet medical needs. They have achieved significant milestones by developing "world's first" innovations in lung cancer, tuberculosis, cardiovascular diseases, and gastroenterology. Their product portfolio includes a variety of dosage forms and they hold several patents for their innovative products.

Manufacturer usually replies in 50 days

rivastigmine tartrate

Capsules 1.5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
Sri Lanka, Afghanistan, Vietnam, Cambodia, Myanmar
Manufacturer #21102

This CTD dossier owner and manufacturer specializes in the manufacturing, import, and export of a diverse range of healthcare products. Their portfolio includes over 300 registered pharmaceutical products spanning various therapeutic areas, primarily delivered through tablets, capsules, dry suspensions, injectables, and sachets. The company operates a state-of-the-art manufacturing facility equipped with modern technology to ensure high-quality production according to international standards. They are committed to research and development, aiming to provide innovative healthcare solutions globally. Their focus extends beyond manufacturing, encompassing market research and the promotion of pharmaceutical products across regions like the EU and North America.

Manufacturer usually replies in 4 days

rivastigmine tartrate

Capsules 1.5 mg, 3 mg, 4.5 mg, 6 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
PICS
Manufacturer #554
This company focuses on developing and manufacturing a range of pharmaceuticals and healthcare products. Their offerings include prescription medications, over-the-counter drugs, and potentially medical devices or supplements, though specifics are not provided. They appear to have a strong research and development focus, with expertise in several key therapy areas (not specified). The company operates within regions like the EU and North America, adhering to stringent GMP certifications for production. While patent information is unavailable, their commitment to innovation is evident through their product development pipeline.

Manufacturer usually replies in 8 days

Want to see all 7 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible